Home › Funds › HOMESTEAD ADVISERS CORP › RPRX

HOMESTEAD ADVISERS CORP position in RPRX

ROYALTY PHARMA PLC · Health Care

HOMESTEAD ADVISERS CORP reported holding 1,657,242 shares of RPRX (ROYALTY PHARMA PLC) in its Q3 2026 13F filing — a position valued at US$96.7M, representing 2.46% of its reported portfolio and ranking #12 among its reported holdings. HOMESTEAD ADVISERS CORP has disclosed RPRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.66M sh
Reported value held$96.68M
Portfolio Weight2.46%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How HOMESTEAD ADVISERS CORP's RPRX position evolved

HOMESTEAD ADVISERS CORP first disclosed a stake in RPRX in Q3 2023 at 1,343,040 shares (US$36.5M). The position peaked in Q3 2026 at 1,657,242 shares, worth US$96.7M. Across 13 filings, HOMESTEAD ADVISERS CORP increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 1,657,242 shares valued at US$96.7M. Notable position changes include a 41% increase in Q1 2024 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.34M $36.45M New
Q4 2023 1.35M $37.80M Hold
Q1 2024 1.89M $57.50M Add
Q2 2024 1.86M $49.05M Reduce
Q3 2024 1.86M $52.57M Hold
Q4 2024 1.93M $49.26M Add
Q1 2025 1.93M $60.12M Hold
Q2 2025 1.94M $69.88M Hold
Q3 2025 1.90M $67.12M Reduce
Q4 2025 1.67M $64.59M Reduce
Q1 2026 1.65M $78.91M Reduce
Q2 2026 1.66M $92.92M Hold
Q3 2026 1.66M $96.68M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RPRX and 13F data

RPRX (ROYALTY PHARMA PLC) is a Health Care company. 47 other funds we track also report a position in RPRX — the largest reported positions include Swedbank AB (US$598.8M), Baillie Gifford & Co (US$534.1M), ROYAL LONDON ASSET MANAGEMENT LTD (US$348.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RPRX

All RPRX fund holders →

FAQ

How long has HOMESTEAD ADVISERS CORP held RPRX?

HOMESTEAD ADVISERS CORP has disclosed RPRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is HOMESTEAD ADVISERS CORP's current position in RPRX?

As of Q3 2026, HOMESTEAD ADVISERS CORP holds 1.66M shares of RPRX (ROYALTY PHARMA PLC), valued at $96.68M, representing 2.46% of its reported portfolio and ranking #12.

Has HOMESTEAD ADVISERS CORP been buying or selling RPRX?

In the latest 13F filing (Q3 2026), HOMESTEAD ADVISERS CORP held unchanged its position in RPRX. The position peaked in Q3 2026 at 1.66M shares.

Which other funds hold RPRX?

Other major institutional holders of RPRX include Swedbank AB, Baillie Gifford & Co, ROYAL LONDON ASSET MANAGEMENT LTD, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.